Start Date
January 31, 2002
Primary Completion Date
September 30, 2003
Study Completion Date
September 30, 2003
gefitinib
Institute for Drug Development, San Antonio
University of Texas Health Science Center at San Antonio, San Antonio
National Cancer Institute (NCI)
NIH
The University of Texas Health Science Center at San Antonio
OTHER